Entero Healthcare Solutions Ltd (ENTERO) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported a strong start to FY27, with consolidated revenue growth of 38.2% YoY, driven by a combination of organic and inorganic growth. On a like-for-like basis, adjusting for certain business model changes and divestments, the growth was even stronger at 40% YoY.
- A significant achievement for the quarter was the meaningful improvement in profitability, with the EBITDA margin reaching 5%, meeting the full-year FY27 guidance in the first quarter itself. This was attributed to scale-led procurement benefits, a higher share of the MedTech business, and the conscious exit from low-margin accounts.
- The company's strategic priority for the year is to consolidate and integrate the significant volume of acquisitions made over the past two years, focusing on organic growth from the established platform. Consequently, no new acquisitions were made in Q1 FY27.
- Capital efficiency showed marked improvement, with Return on Capital Employed (ROCE) nearly doubling to 21.1% from 11.5% YoY, and Return on Equity (ROE) increasing to 20.4% from 9% YoY, demonstrating that growth is being achieved with capital discipline.
- The company maintained its FY27 guidance, projecting approximately 23% YoY consolidated revenue growth (excluding new acquisitions), an EBITDA margin of 5%, and an EBITDA to operating cash flow conversion of 50%.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.